6039 Japan Animal Referral Medical Center Co.,Ltd. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

6039

TSE Growth

Japan Animal Referral Medical Center Co.,Ltd.

1,280

JPY

-1

(-0.08%)

Mar 13, 3:30 pm JST

8.03

USD

Mar 13, 2:30 am EDT

Result

PTS

outside of trading hours

1,261

Mar 13, 11:06 pm JST

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2022	2,979	439	438	286	24.2	0	May 12, 2022	J-GAAP
Mar, 2023	3,872	580	534	380	31.3	0	May 11, 2023	J-GAAP
Mar, 2024	4,270	496	489	337	24.6	4	May 9, 2024	J-GAAP
Mar, 2025	5,277	720	720	520	40.2	7.40	May 15, 2025	J-GAAP
Mar, 2026 Guidance	6,100	1,040	1,030	730	56.5	8	Nov 20, 2025	J-GAAP
YoY	+15.6%	+44.4%	+43.1%	+40.4%	+40.4%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Mar, 2021	May 7, 2020	2,800	435	445	315	0	J-GAAP
Results	May 6, 2021	2,847	405	410	285	0	J-GAAP
Mar, 2022	May 6, 2021	Available in future release
Results	May 12, 2022
Mar, 2023	May 12, 2022
Results	May 11, 2023
Mar, 2024	May 11, 2023
Results	May 9, 2024
Mar, 2025	May 9, 2024
	Feb 14, 2025
Results	May 15, 2025
Mar, 2026	May 15, 2025	5,810	725	725	525	8*	J-GAAP
	Aug 14, 2025	5,960	857	857	610	8*	J-GAAP
	Nov 13, 2025	6,100	1,040	1,030	730	8*	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Mar, 2010	878	－	Available in future release
Mar, 2011	1,040	+18.5
Mar, 2012	1,207	+16.1
Mar, 2013	1,327	+9.9
Mar, 2014	1,481	+11.6
Mar, 2015	1,894	+27.9
Mar, 2016	2,093	+10.5
Mar, 2017	2,191	+4.7
Mar, 2018	2,258	+3.1
Mar, 2019	2,563	+13.5
Mar, 2020	2,734	+6.7
Mar, 2021	2,847	+4.1
Mar, 2022	2,979	+4.6
Mar, 2023	3,872	+30.0
Mar, 2024	4,270	+10.3
Mar, 2025	5,277	+23.6
Mar, 2026 Guidance	6,100	+15.6	1,040	+44.4	1,030	+43.1	56.5	+40.5

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Mar, 2024	4,270	496	11.6	8.97	3.89	0.49	24.6
Mar, 2025	5,277	720	13.6	13.07	5.94	0.60	40.2
Mar, 2026 Guidance	6,100	1,040	17.1	15.46	7.88	0.66	56.5

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	5,277	720	720	520	40.2
Fiscal Year	Mar, 2025	Mar, 2025	Mar, 2025	Mar, 2025	Mar, 2025

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2022	1,957	287	239	183	15.1	0	May 11, 2023	J-GAAP
Oct - Mar, 2023	2,288	337	337	240	17.5	4	May 9, 2024	J-GAAP
Oct - Mar, 2024	2,708	370	369	278	21.5	7.40	May 15, 2025	J-GAAP
Oct - Mar, 2025 Guidance	3,067	449	441	317	24.5	8	Nov 20, 2025	J-GAAP
YoY	+13.3%	+21.4%	+19.5%	+14.0%	+14.1%

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Mar, 2023	580	26	810	-784	820	1,816	21.17	J-GAAP
Mar, 2024	496	-86	899	-985	-392	1,337	15.25	J-GAAP
Mar, 2025	720	378	1,372	-994	-608	1,107	12.65	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Dec, 2023	3,115	345	335	220	16.0	68.5	Feb 8, 2024	J-GAAP
Apr - Dec, 2024	3,942	590	590	409	31.6	81.9	Feb 14, 2025	J-GAAP
Apr - Dec, 2025	4,660	966	962	675	52.2	93.4	Feb 16, 2026	J-GAAP
YoY	+18.2%	+63.7%	+63.1%	+65.0%	+65.5%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jan - Mar, 2024	1,155	151	154	117	8.5	13.1	May 9, 2024	J-GAAP
Apr - Jun, 2024	1,250	149	150	103	7.9	11.9	Aug 1, 2024	J-GAAP
Jul - Sep, 2024	1,319	201	201	139	10.8	15.2	Nov 7, 2024	J-GAAP
Oct - Dec, 2024	1,373	240	239	167	12.9	17.5	Feb 14, 2025	J-GAAP
Jan - Mar, 2025	1,335	130	130	111	8.6	9.7	May 15, 2025	J-GAAP
Apr - Jun, 2025	1,473	258	258	180	14.0	17.5	Aug 14, 2025	J-GAAP
Jul - Sep, 2025	1,560	333	331	233	18.0	21.3	Nov 13, 2025	J-GAAP
Oct - Dec, 2025	1,627	375	373	262	20.3	23.0	Feb 16, 2026	J-GAAP
YoY	+18.5%	+56.3%	+56.1%	+56.9%	+57.3%

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Jan - Mar, 2021	716	+4.4	Available in future release
Apr - Jun, 2021	719	+2.9
Jul - Sep, 2021	718	+1.0
Oct - Dec, 2021	793	+10.0
Jan - Mar, 2022	749	+4.6
Apr - Jun, 2022	934	+29.9
Jul - Sep, 2022	981	+36.6
Oct - Dec, 2022	1,000	+26.1
Jan - Mar, 2023	957	+27.8
Apr - Jun, 2023	951	+1.8
Jul - Sep, 2023	1,031	+5.1
Oct - Dec, 2023	1,133	+13.3
Jan - Mar, 2024	1,155	+20.7
Apr - Jun, 2024	1,250	+31.4
Jul - Sep, 2024	1,319	+27.9
Oct - Dec, 2024	1,373	+21.2
Jan - Mar, 2025	1,335	+15.6
Apr - Jun, 2025	1,473	+17.8
Jul - Sep, 2025	1,560	+18.3
Oct - Dec, 2025	1,627	+18.5	375	+56.3	373	+56.1	20.3	+57.4

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	1,627	375	373	262	20.3
Fiscal Year	Dec, 2025	Dec, 2025	Dec, 2025	Dec, 2025	Dec, 2025

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Mar, 2023	1,354.99	43.2	8,578	3,706	2,375	1.07	May 11, 2023	J-GAAP
Mar, 2024	1,446.52	43.5	8,770	3,811	2,712	1.01	May 9, 2024	J-GAAP
Mar, 2025	1,604.99	47.4	8,753	4,148	3,179	0.84	May 15, 2025	J-GAAP
Apr - Dec, 2025	ー	51.0	9,265	4,723	3,754	0.71	Feb 16, 2026	J-GAAP

Japan Animal Referral Medical Center Co.,Ltd.(6039) Financial Results